What activates the complement system?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 28, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Activation Pathways of the Complement System

The complement system is activated through three distinct pathways: the classical pathway, the alternative pathway, and the lectin pathway, each triggered by different molecular mechanisms and converging at the formation of C3 convertase. 1

Classical Pathway Activation

  • Triggered by antigen-antibody complexes: The classical pathway is primarily activated when antibodies (IgG or IgM) bind to antigens, forming immune complexes 2
  • C1 complex initiation: These immune complexes are recognized by C1q (part of the C1 complex), which then activates C1r and C1s
  • Subsequent activation: C1s cleaves C4 and C2, forming C4b2a (C3 convertase)
  • Diagnostic indicators: Low CH50 with normal AH50 suggests deficiency in C1, C2, or C4 components 2

Alternative Pathway Activation

  • Spontaneous activation: The alternative pathway is continuously activated at a low level through spontaneous hydrolysis of C3 ("tickover")
  • Amplification loop: Factor B binds to C3b, followed by Factor D cleavage, forming C3bBb (alternative C3 convertase)
  • Properdin stabilization: Properdin stabilizes C3bBb, extending its half-life
  • Surface triggers: Microbial surfaces lacking regulatory proteins can trigger this pathway
  • Diagnostic indicators: Normal CH50 with low AH50 suggests properdin defect or Factor B/D deficiency 2

Lectin Pathway Activation

  • Pattern recognition: Initiated by mannose-binding lectin (MBL) or ficolins binding to carbohydrate patterns on pathogen surfaces 3
  • MBL-MASP complex: In humans, MBL and three types of ficolins (L-ficolin, H-ficolin, M-ficolin) form complexes with MBL-associated serine proteases (MASPs) 3
  • MASP activation: Upon binding to pathogens, MASP-1 activates MASP-2, which then cleaves C4 and C2 3
  • C3 convertase formation: This leads to the formation of C4b2a (C3 convertase), similar to the classical pathway

Common Terminal Pathway

  • C3 convertase: All three pathways converge at the formation of C3 convertase (C4b2a or C3bBb)
  • C3 cleavage: C3 convertase cleaves C3 into C3a and C3b
  • C5 convertase formation: C3b joins with C3 convertase to form C5 convertase
  • Membrane attack complex (MAC): C5 convertase cleaves C5, initiating the assembly of C5b-C9 to form MAC, which creates pores in target cell membranes leading to lysis 2, 4

Complement Regulation

  • Regulatory proteins: The complement system is tightly regulated by proteins such as Factor H, Factor I, CD46, CD55, and CD59 2
  • Dysregulation consequences: Deficiencies in regulatory components can lead to complement consumption and pathological conditions 2
  • Diagnostic approach: Measuring levels of factor B and C4 can help identify consumption of complement through alternative or classical pathways, respectively 2

Clinical Implications

  • Infection susceptibility: Deficiencies in complement components increase susceptibility to specific infections 3
  • Autoimmune diseases: Dysregulation can contribute to autoimmune conditions like atypical hemolytic uremic syndrome 4
  • Inflammatory disorders: Complement activation plays a role in inflammatory conditions and tissue damage 4
  • Diagnostic testing: CH50 and AH50 assays help identify pathway-specific deficiencies 2

Understanding these activation pathways is crucial for diagnosing complement-related disorders and developing targeted therapeutic approaches that modulate specific parts of the complement cascade.

References

Guideline

Coagulation and Hemostasis

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.